Structure–activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide

Claudio Trapella(University of Ferrara), Severo Salvadori(University of Ferrara), Carmela Fischetti, David G. Lambert(Griffith University), Michela Pelà(University of Ferrara), Ilaria Lazzari(University of Ferrara), Remo Guerrini(University of Ferrara), D. Regoli(University of Ferrara), Anna Rizzi(University of Ferrara), Valeria Camarda(University of Ferrara), John McDonald, Girolamo Calò(University of Padua)

Bioorganic & Medicinal Chemistry

June 3, 2009

Cited by 29

|British Journal of Pharmacology|2021|488

|Nature|2012|474

|British Journal of Pharmacology|2000|432

|British Journal of Pharmacology|2023|390

|Trends in Pharmacological Sciences|1988|358

Related Papers